Amylyx Pharmaceuticals, Inc. ETF Holding It
Amylyx Pharmaceuticals, Inc. (AMLX). 11 retained portfolio positions. Missing dates and values remain unreported.
- AVSC: Fund Avantis U.S. Small Cap Equity ETF; Weight 0.04%; Value (USD) $606.06K; Added / first observed 2024-02-29.
- BBC: Fund Virtus Biotech Clinical Trials Etf; Weight 0.90%; Value (USD) $337.09K; Added / first observed 2026-01-30.
- FAD: Fund First Trust Multi Cap Growth AlphaDEX Fund; Weight 0.05%; Value (USD) $250.66K; Added / first observed 2023-04-28.
- FSCC: Fund Federated Hermes MDT Small Cap Core ETF; Weight 0.30%; Value (USD) $455.83K; Added / first observed 2025-02-28.
ETF Holding It
11 retained portfolio positions. Missing dates and values remain unreported.
| ETF | Fund | Weight | Value (USD) | Added / first observed | Latest report |
|---|---|---|---|---|---|
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.04% | $606.06K | 2024-02-29 | 2025-05-31 |
| BBC | Virtus Biotech Clinical Trials Etf | 0.90% | $337.09K | 2026-01-30 | 2026-04-30 |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.05% | $250.66K | 2023-04-28 | 2026-04-30 |
| FSCC | Federated Hermes MDT Small Cap Core ETF | 0.30% | $455.83K | 2025-02-28 | 2026-02-28 |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 0.26% | $2.69M | 2023-04-28 | 2026-04-30 |
| FYX | First Trust Small Cap Core AlphaDEX Fund | 0.07% | $796.98K | 2023-04-28 | 2026-04-30 |
| GSSC | Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF | 0.08% | $718.45K | 2023-08-31 | 2026-02-28 |
| ISCB | iShares Morningstar Small-Cap ETF | 0.02% | $56.94K | 2022-10-31 | 2026-04-30 |
| IWV | iShares Russell 3000 ETF | 0.00% | $330.76K | 2022-09-30 | 2026-03-31 |
| OPTZ | Optimize Strategy Index ETF | 0.21% | $444.81K | 2026-03-31 | 2026-03-31 |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.07% | $53.20K | 2025-04-30 | 2026-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |